Transrectal contrast enhanced ultrasound for diagnosis of prostate cancer.
The diagnosis of prostate cancer is based on histology. Prostate biopsies are obtained based on the triad of prostate specific antigen (PSA), digital rectal examination (DRE) and transrectal ultrasound. Because prostate biopsies still have a large percentage of negative outcomes, patient selection and biopsy direction need improvement. This paper describes the recent improvements in prostate cancer imaging, especially contrast-enhanced transrectal ultrasound.
Wink
M H
MH
Department of Urology (G4-105), Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, ZO, The Netherlands.
de la Rosette
J J M C H
JJ
Grimbergen
C A
CA
Wijkstra
H
H
D000285:Administration, Rectal; D003287:Contrast Media / Q000008:administration & dosage*; D019160:Endosonography / Q000379:methods*; D006801:Humans; D008297:Male; D045423:Microbubbles; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging*; D015203:Reproducibility of Results
D003287:Contrast Media